首页 > 最新文献

中华消化杂志最新文献

英文 中文
Mechanism of infliximab in preventing autoimmune hepatitis in mice model 英夫利昔单抗预防小鼠自身免疫性肝炎的机制
Pub Date : 2020-03-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.03.011
Mengyu Sun, C. Wan, Mengnan Lyu, Yan Song, R. Ma, Wen-tian Liu
Objective To observe the preventive effects of infliximab in autoimmune hepatitis (AIH) and to explore its mechanism. Methods The mice AIH model was established by injecting concanavalin A (Con-A) into the caudal vein. Forty mice were divided into prevention group and control group, with 20 mice in each group. The mice of prevention group were injected intravenously with infliximab (20 mg/kg) one hour before Con-A injection and the mice of control group were administrated with 200 μL phosphate buffered saline (PBS). Serum was collected 3, 8, 12 and 24 h after Con-A/PBS injection. The serum level of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) was detected by colorimetry. The level of cytokine interleukin (IL)-6, IL-1β, interferon gamma (IFN-γ), IL-4, IL-17A, IL-10 and chemokine C-X-C motif ligand 10 (CXCL10) was measured by enzyme-linked immunosorbent assay (ELISA). Liver samples were taken 12 h after Con-A/PBS injection for hematoxylin-eosin staining. Liver infiltrated lymphocytes were assessed by flow cytometry. The expression of T-box transcription factor 21 (TBX21), GATA binding protein 3 (GATA3), RAR related orphan receptor C (RORC) and CXCL10 at mRNA level was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR). The expression of CXCL10 in liver was detected by Western blotting. Paired t test and one-way analysis of variance were used for statistic analysis. Results At 8, 12, and 24 h after Con-A injection, the serum ALT level, AST level, IL-1β and IFN-γ of prevention group were all lower than those of control group ((545.8±190.3) U/L vs. (865.8±237.7) U/L, (947.6±267.9) U/L vs. (1 448.0±403.5) U/L, (508.6±131.1) U/L vs. (976.6±207.6) U/L; (620.7±132.0) U/L vs. (952.9±106.8) U/L, (801.6±212.0) U/L vs. (1 424.8±236.0) U/L, (632.1±117.8) U/L vs. (1 008.3±187.5) U/L; (31.38±10.12) ng/L vs. (48.12±11.53) ng/L, (39.34±11.40) ng/L vs. (60.00±14.17) ng/L, (29.49±8.22) ng/L vs. (46.89±5.50) ng/L; and (432.93±66.82) ng/L vs. (674.66±97.88) ng/L, (655.09±169.17) ng/L vs. (937.90±166.36) ng/L, (263.40±54.97) ng/L vs. (410.74±86.64) ng/L), and the differences were statistically significant (t = 2.350, 2.308, 4.263, 4.374, 4.860, 3.806, 2.440, 2.541, 3.939, 4.560, 2.660 and 3.210; all P 0.05). Conclusions Infliximab has certain preventive effects in mice AIH model, which may be achieved by antagonizing TNF-α and decreasing the expression of CXCL10 in liver, reducing the infiltration of T-helper 1 cells and CD8+ T cells into liver, and by reducing T lymphocyte activation induced by inflammatory cytokines thus alleviating the damage of T lymphocytes to hepatocytes. Key words: Hepatitis, autoimmune; Infliximab; C-X-C motif chemokine ligand 10; Mice
目的观察英夫利昔单抗对自身免疫性肝炎(AIH)的预防作用,并探讨其作用机制。方法采用尾静脉注射刀豆蛋白A (cona)建立小鼠AIH模型。将40只小鼠分为预防组和对照组,每组20只。预防组小鼠在注射Con-A前1 h静脉注射英夫利昔单抗(20 mg/kg),对照组小鼠灌胃200 μL磷酸缓冲盐水(PBS)。注射Con-A/PBS后3、8、12、24 h采集血清。采用比色法检测血清谷草转氨酶(AST)和丙氨酸转氨酶(ALT)水平。采用酶联免疫吸附法(ELISA)检测细胞因子白介素(IL)-6、IL-1β、干扰素γ (IFN-γ)、IL-4、IL- 17a、IL-10和趋化因子C-X-C基序配体10 (CXCL10)的水平。注射Con-A/PBS后12 h取肝脏标本进行苏木精-伊红染色。流式细胞术检测肝脏浸润淋巴细胞。采用实时荧光定量聚合酶链式反应(qRT-PCR)检测T-box转录因子21 (TBX21)、GATA结合蛋白3 (GATA3)、RAR相关孤儿受体C (RORC)和CXCL10 mRNA水平的表达。Western blotting检测CXCL10在肝脏中的表达。采用配对t检验和单因素方差分析进行统计分析。结果Con-A注射后8、12、24 h,预防组血清ALT水平、AST水平、IL-1β、IFN-γ均低于对照组((545.8±190.3)U/L比(865.8±237.7)U/L,(947.6±267.9)U/L比(1 448.0±403.5)U/L,(508.6±131.1)U/L比(976.6±207.6)U/L;(620.7±132.0)U / L和(952.9±106.8)/ L, U / L(801.6±212.0)和(424.8±236.0)U / L, U / L(632.1±117.8)和(008.3±187.5)U / L;(31.38±10.12)ng / L和(48.12±11.53)ng / L ng / L(39.34±11.40)和(60.00±14.17)ng / L ng / L(29.49±8.22)和(46.89±5.50)ng / L;(432.93±66.82)ng/L vs(674.66±97.88)ng/L,(655.09±169.17)ng/L vs(937.90±166.36)ng/L,(263.40±54.97)ng/L vs(410.74±86.64)ng/L),差异均有统计学意义(t = 2.350、2.308、4.263、4.374、4.860、3.806、2.440、2.541、3.939、4.560、2.660、3.210;P < 0.05)。结论英夫利昔单抗对小鼠AIH模型具有一定的预防作用,其机制可能是拮抗TNF-α,降低肝脏中CXCL10的表达,减少T-辅助性1细胞和CD8+ T细胞向肝脏的浸润,减少炎症因子诱导的T淋巴细胞活化,从而减轻T淋巴细胞对肝细胞的损伤。关键词:肝炎;自身免疫;英夫利昔单抗;C-X-C基序趋化因子配体;老鼠
{"title":"Mechanism of infliximab in preventing autoimmune hepatitis in mice model","authors":"Mengyu Sun, C. Wan, Mengnan Lyu, Yan Song, R. Ma, Wen-tian Liu","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.03.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.03.011","url":null,"abstract":"Objective \u0000To observe the preventive effects of infliximab in autoimmune hepatitis (AIH) and to explore its mechanism. \u0000 \u0000 \u0000Methods \u0000The mice AIH model was established by injecting concanavalin A (Con-A) into the caudal vein. Forty mice were divided into prevention group and control group, with 20 mice in each group. The mice of prevention group were injected intravenously with infliximab (20 mg/kg) one hour before Con-A injection and the mice of control group were administrated with 200 μL phosphate buffered saline (PBS). Serum was collected 3, 8, 12 and 24 h after Con-A/PBS injection. The serum level of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) was detected by colorimetry. The level of cytokine interleukin (IL)-6, IL-1β, interferon gamma (IFN-γ), IL-4, IL-17A, IL-10 and chemokine C-X-C motif ligand 10 (CXCL10) was measured by enzyme-linked immunosorbent assay (ELISA). Liver samples were taken 12 h after Con-A/PBS injection for hematoxylin-eosin staining. Liver infiltrated lymphocytes were assessed by flow cytometry. The expression of T-box transcription factor 21 (TBX21), GATA binding protein 3 (GATA3), RAR related orphan receptor C (RORC) and CXCL10 at mRNA level was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR). The expression of CXCL10 in liver was detected by Western blotting. Paired t test and one-way analysis of variance were used for statistic analysis. \u0000 \u0000 \u0000Results \u0000At 8, 12, and 24 h after Con-A injection, the serum ALT level, AST level, IL-1β and IFN-γ of prevention group were all lower than those of control group ((545.8±190.3) U/L vs. (865.8±237.7) U/L, (947.6±267.9) U/L vs. (1 448.0±403.5) U/L, (508.6±131.1) U/L vs. (976.6±207.6) U/L; (620.7±132.0) U/L vs. (952.9±106.8) U/L, (801.6±212.0) U/L vs. (1 424.8±236.0) U/L, (632.1±117.8) U/L vs. (1 008.3±187.5) U/L; (31.38±10.12) ng/L vs. (48.12±11.53) ng/L, (39.34±11.40) ng/L vs. (60.00±14.17) ng/L, (29.49±8.22) ng/L vs. (46.89±5.50) ng/L; and (432.93±66.82) ng/L vs. (674.66±97.88) ng/L, (655.09±169.17) ng/L vs. (937.90±166.36) ng/L, (263.40±54.97) ng/L vs. (410.74±86.64) ng/L), and the differences were statistically significant (t = 2.350, 2.308, 4.263, 4.374, 4.860, 3.806, 2.440, 2.541, 3.939, 4.560, 2.660 and 3.210; all P 0.05). \u0000 \u0000 \u0000Conclusions \u0000Infliximab has certain preventive effects in mice AIH model, which may be achieved by antagonizing TNF-α and decreasing the expression of CXCL10 in liver, reducing the infiltration of T-helper 1 cells and CD8+ T cells into liver, and by reducing T lymphocyte activation induced by inflammatory cytokines thus alleviating the damage of T lymphocytes to hepatocytes. \u0000 \u0000 \u0000Key words: \u0000Hepatitis, autoimmune; Infliximab; C-X-C motif chemokine ligand 10; Mice","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"25 1","pages":"192-198"},"PeriodicalIF":0.0,"publicationDate":"2020-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82851542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and risk factors of gastrointestinal symptoms in patients with novel coronavirus pneumonia in Xinyang, Henan province 河南省信阳市新型冠状病毒肺炎患者胃肠道症状临床特征及危险因素分析
Pub Date : 2020-03-14 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.0011
Ye-ting Zhao, S. Zhong, Fang Li, Gang Liu, Xinfang Wang, Zhanju Liu
回顾性分析信阳市第五人民医院106例成人新型冠状病毒肺炎(COVID-19)患者的临床特征,了解河南省信阳地区COVID-19患者消化道症状临床特征和危险因素。筛选合并消化道症状8例患者为病例组,无消化道症状16例患者为对照组,结果发现病例组与对照组的临床症状、基础疾病和流行病学特征比较差异均无统计学意义(P均>0.05)。病例组中性粒细胞计数、C反应蛋白(CRP)、直接胆红素和肌红蛋白水平均高于对照组,差异均有统计学意义,OR值(95% CI)分别为2.021(1.012~2.123)、1.015(1.002~1.028)、1.062(1.008~1.357)和1.091(1.000~1.921),P均<0.05)。CRP水平升高是COVID-19患者出现消化道症状的独立危险因素(P < 0.05)。COVID-19患者合并消化道症状发生率为7.55%(8/106),有消化道症状者炎症活动和器官受累情况比无消化道症状者严重。
回顾性分析信阳市第五人民医院106例成人新型冠状病毒肺炎(COVID-19)患者的临床特征,了解河南省信阳地区COVID-19患者消化道症状临床特征和危险因素。筛选合并消化道症状8例患者为病例组,无消化道症状16例患者为对照组,结果发现病例组与对照组的临床症状、基础疾病和流行病学特征比较差异均无统计学意义(P均>0.05)。病例组中性粒细胞计数、C反应蛋白(CRP)、直接胆红素和肌红蛋白水平均高于对照组,差异均有统计学意义,OR值(95% CI)分别为2.021(1.012~2.123)、1.015(1.002~1.028)、1.062(1.008~1.357)和1.091(1.000~1.921),P均<0.05)。CRP水平升高是COVID-19患者出现消化道症状的独立危险因素(P < 0.05)。COVID-19患者合并消化道症状发生率为7.55%(8/106),有消化道症状者炎症活动和器官受累情况比无消化道症状者严重。
{"title":"Clinical characteristics and risk factors of gastrointestinal symptoms in patients with novel coronavirus pneumonia in Xinyang, Henan province","authors":"Ye-ting Zhao, S. Zhong, Fang Li, Gang Liu, Xinfang Wang, Zhanju Liu","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.0011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.0011","url":null,"abstract":"回顾性分析信阳市第五人民医院106例成人新型冠状病毒肺炎(COVID-19)患者的临床特征,了解河南省信阳地区COVID-19患者消化道症状临床特征和危险因素。筛选合并消化道症状8例患者为病例组,无消化道症状16例患者为对照组,结果发现病例组与对照组的临床症状、基础疾病和流行病学特征比较差异均无统计学意义(P均>0.05)。病例组中性粒细胞计数、C反应蛋白(CRP)、直接胆红素和肌红蛋白水平均高于对照组,差异均有统计学意义,OR值(95% CI)分别为2.021(1.012~2.123)、1.015(1.002~1.028)、1.062(1.008~1.357)和1.091(1.000~1.921),P均<0.05)。CRP水平升高是COVID-19患者出现消化道症状的独立危险因素(P < 0.05)。COVID-19患者合并消化道症状发生率为7.55%(8/106),有消化道症状者炎症活动和器官受累情况比无消化道症状者严重。","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81310457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Manifestations of liver injury in 333 hospitalized patients with coronavirus disease 2019 333例2019冠状病毒病住院患者肝损伤分析
Pub Date : 2020-03-09 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.03.004
Shuhui Wang, P. Han, Fang Xiao, Xiaofen Huang, Liping Cao, Zhenzhen Zhou, Shuai Xing, Jian Han, Liping Chen, Mi Wang, J. Dai, Q. Ding, S. Xiong, Wang Wei, Nan Meng, D. Tian, Wei Yan
Objective To investigate the manifestations of liver injury in hospitalized patients with coronavirus disease 2019 (COVID-19), to investigate the prognosis indicators of the disease, and to provide the reference for clinical diagnosis and treatment. Methods From January 10 to February 14, 2020, at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, the data of 333 hospitalized patients with COVID-19 were collected. The changes of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBil), direct bilirubin (DBil), indirect bilirubin (IBil) and albumin of the first liver function test after admission and the reexaminations of liver function test during hospitalization period in patients with liver injury were retrospectively analyzed. Student t test and Chi-square test were used for statistical analysis. Results Liver injury occurred in 39.6% (132/333) of COVID-19 patients. There was no statistically significant difference in the rate of liver injury between patients in intensive care unit (ICU) and in general ward (45.6%, 26/57 vs. 38.4%, 106/276; χ2=1.026, P>0.05). 67.4% (89/132) of COVID-19 patients with liver injury presented with increased ALT or AST level on admission. During hospitalization, the level of ALT was higher than that of the first examination after admission ((60.28±50.44) U/L vs. (42.25±32.21) U/L), and the difference was statistically significant (t=-3.230, P<0.05). The levels of ALT and AST of 71.2% (94/132) patients were both <80 U/L, which indicated that most of the patients showed mild liver injury. The patients with elevated level of TBil, DBil and IBil accounted for 3.9% (13/333), 5.4% (18/333) and 2.4% (8/333) of the COVID-19 patients, respectively. The albumin level of COVID-19 patients with liver injury during hospitalization was lower than that of the first examination after admission ((31.8±5.1) g/L vs. (33.7±5.4) g/L), and the difference was statistically significant (t=2.712, P<0.05). The albumin levels at first examination on admission and reexamination during hospitalization of patients in ICU were both significantly lower than those of patients in general ward ((29.3±3.7) g/L vs. (34.8±5.1) g/L and (27.6±2.8) g/L vs. (32.9±5.1) g/L), and the differences were statistically significant (t=4.928 and 4.783, both P<0.05). Conclusions The incidence of liver injury in COVID-19 patients is high. A slight increase in aminotransferase levels is particularly common. Bilirubin abnormality is relatively rare and mild. The level of albumin may be one of the indicators for the severity and prognosis of COVID-19. Key words: 2019-nCoV; COVID-19; Liver injury; Albumin
目的探讨2019冠状病毒病(COVID-19)住院患者肝损伤的临床表现,探讨该病的预后指标,为临床诊治提供参考。方法收集2020年1月10日至2月14日华中科技大学同济医学院同济医院收治的333例新冠肺炎住院患者的资料。回顾性分析肝损伤患者入院后第一次肝功能检查及住院期间复查肝功能检查时丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素(TBil)、直接胆红素(DBil)、间接胆红素(IBil)、白蛋白的变化。采用学生t检验和卡方检验进行统计分析。结果39.6%(132/333)的患者出现肝损伤。重症监护病房(ICU)与普通病房患者肝损伤发生率比较,差异无统计学意义(45.6%,26/57比38.4%,106/276;χ2 = 1.026,P > 0.05)。67.4%(89/132)的新冠肺炎肝损伤患者入院时ALT或AST水平升高。住院期间ALT水平高于入院后第一次检查时(60.28±50.44)U/L∶(42.25±32.21)U/L,差异有统计学意义(t=-3.230, P<0.05)。71.2%(94/132)患者的ALT和AST水平均<80 U/L,表明大多数患者为轻度肝损伤。TBil、DBil和IBil水平升高的患者分别占COVID-19患者的3.9%(13/333)、5.4%(18/333)和2.4%(8/333)。新冠肺炎肝损伤患者住院期间白蛋白水平低于入院后首次检查时((31.8±5.1)g/L vs(33.7±5.4)g/L),差异有统计学意义(t=2.712, P<0.05)。ICU患者入院初检及住院复检时白蛋白水平均显著低于普通病房患者((29.3±3.7)g/L∶(34.8±5.1)g/L、(27.6±2.8)g/L∶(32.9±5.1)g/L),差异均有统计学意义(t=4.928、4.783,P均<0.05)。结论新冠肺炎患者肝损伤发生率高。转氨酶水平的轻微升高尤其常见。胆红素异常是比较少见和轻微的。白蛋白水平可能是判断COVID-19病情严重程度和预后的指标之一。关键词:新型冠状病毒;COVID-19;肝损伤;白蛋白
{"title":"Manifestations of liver injury in 333 hospitalized patients with coronavirus disease 2019","authors":"Shuhui Wang, P. Han, Fang Xiao, Xiaofen Huang, Liping Cao, Zhenzhen Zhou, Shuai Xing, Jian Han, Liping Chen, Mi Wang, J. Dai, Q. Ding, S. Xiong, Wang Wei, Nan Meng, D. Tian, Wei Yan","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.03.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.03.004","url":null,"abstract":"Objective \u0000To investigate the manifestations of liver injury in hospitalized patients with coronavirus disease 2019 (COVID-19), to investigate the prognosis indicators of the disease, and to provide the reference for clinical diagnosis and treatment. \u0000 \u0000 \u0000Methods \u0000From January 10 to February 14, 2020, at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, the data of 333 hospitalized patients with COVID-19 were collected. The changes of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBil), direct bilirubin (DBil), indirect bilirubin (IBil) and albumin of the first liver function test after admission and the reexaminations of liver function test during hospitalization period in patients with liver injury were retrospectively analyzed. Student t test and Chi-square test were used for statistical analysis. \u0000 \u0000 \u0000Results \u0000Liver injury occurred in 39.6% (132/333) of COVID-19 patients. There was no statistically significant difference in the rate of liver injury between patients in intensive care unit (ICU) and in general ward (45.6%, 26/57 vs. 38.4%, 106/276; χ2=1.026, P>0.05). 67.4% (89/132) of COVID-19 patients with liver injury presented with increased ALT or AST level on admission. During hospitalization, the level of ALT was higher than that of the first examination after admission ((60.28±50.44) U/L vs. (42.25±32.21) U/L), and the difference was statistically significant (t=-3.230, P<0.05). The levels of ALT and AST of 71.2% (94/132) patients were both <80 U/L, which indicated that most of the patients showed mild liver injury. The patients with elevated level of TBil, DBil and IBil accounted for 3.9% (13/333), 5.4% (18/333) and 2.4% (8/333) of the COVID-19 patients, respectively. The albumin level of COVID-19 patients with liver injury during hospitalization was lower than that of the first examination after admission ((31.8±5.1) g/L vs. (33.7±5.4) g/L), and the difference was statistically significant (t=2.712, P<0.05). The albumin levels at first examination on admission and reexamination during hospitalization of patients in ICU were both significantly lower than those of patients in general ward ((29.3±3.7) g/L vs. (34.8±5.1) g/L and (27.6±2.8) g/L vs. (32.9±5.1) g/L), and the differences were statistically significant (t=4.928 and 4.783, both P<0.05). \u0000 \u0000 \u0000Conclusions \u0000The incidence of liver injury in COVID-19 patients is high. A slight increase in aminotransferase levels is particularly common. Bilirubin abnormality is relatively rare and mild. The level of albumin may be one of the indicators for the severity and prognosis of COVID-19. \u0000 \u0000 \u0000Key words: \u00002019-nCoV; COVID-19; Liver injury; Albumin","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"15 1","pages":"157-161"},"PeriodicalIF":0.0,"publicationDate":"2020-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87370036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
A survey on awareness of digestive system injury caused by corona virus disease 2019 in gastroenterologists/ 中华消化杂志 胃肠科医师2019冠状病毒病致消化系统损伤认知调查
Pub Date : 2020-03-03 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.03.005
Hui Liu, Bin Wang, Kaijun Liu, Liangzhi Wen, Xing-wei Wang, Qin Li, Huiru Zhang, Dongfeng Chen, Yanling Wei, Hongli Cui, Yanmei Zhang
Objective@#To investigate awareness of digestive system injury caused by corona virus disease 2019 (COVID-19) in gastroenterologists.@*Methods@#From February 21 to 23 in 2020, the electronic questionnaire was sent out to explore the condition of the basic knowledge of COVID-19 and knowledge of digestive system injury caused by COVID-19 grasped by gastroenterologists. Chi-square test was used for statistical analysis.@*Results@#A total of 2 216 gastroenterologists from 31 provinces, autonomous regions and municipalities nationwide completed the survey. 99.7% (2 209/2 216) of gastroenterologists stated that they had read the COVID-19 diagnosis and treatment guidelines. The percentage of physicians who well knew the diagnostic criteria of suspected and confirmed cases of COVID-19 was 34.9% (774/2 216) and 39.4% (874/2 216), respectively. The percentage of physician who gave the right answer of COVID-19 detectable methods and lung imaging was 68.4% (1 516/2 216) and 71.6% (1 586/2 216), respectively. The percentage of correct answer of digestive system injury caused by COVID-19 in residents, attending physicians, associate chief physicians and chief physicians was 30.9% (134/433), 33.9% (234/691), 32.4% (213/657) and 34.9% (152/435), respectively, however there were no statistically significant differences among physicians of different level (χ2=6.60, P> 0.05). 95.6% (2 119/2 216) of gastroenterologists believed that probiotics could effectively improve bowel function, and 94.0% (2 082/2 216) of gastroenterologists considered that enteral nutrition support could improve patients’ prognosis.@*Conclusions@#The knowledge and dynamic progress of the digestive system injury caused of COVID-19 are still insufficiently grasped by gastroenterologists in China. So it is necessary to carry out systematic and pertinent training for them.
目的了解胃肠科医师对2019冠状病毒病(COVID-19)致消化系统损伤的认知情况。方法:于2020年2月21日至23日,通过电子问卷调查,了解我院消化内科医师对新冠肺炎的基础知识和新冠肺炎致消化系统损伤的知识掌握情况。采用卡方检验进行统计分析。@*结果@#共有来自全国31个省、自治区、直辖市的2216名胃肠病学家完成调查。99.7%(2 209/2 216)的胃肠科医师表示阅读过新冠肺炎诊疗指南。熟悉新冠肺炎疑似病例和确诊病例诊断标准的医师比例分别为34.9%(774/2 216)和39.4%(874/2 216)。对新冠肺炎检测方法和肺部影像学检查的正确率分别为68.4%(1 516/2 216)和71.6%(1 586/2 216)。住院医师、主治医师、副主任医师、主任医师对新冠肺炎致消化系统损伤的正确率分别为30.9%(134/433)、33.9%(234/691)、32.4%(213/657)、34.9%(152/435),不同级别医师间差异无统计学意义(χ2=6.60, P> 0.05)。95.6%(2 119/2 216)的胃肠科医师认为益生菌能有效改善肠道功能,94.0%(2 082/2 216)的胃肠科医师认为肠内营养支持能改善患者预后。@*结论@#中国消化科医师对COVID-19致消化系统损伤的认识和动态进展仍不充分。因此,有必要对他们进行系统的、有针对性的培训。
{"title":"A survey on awareness of digestive system injury caused by corona virus disease 2019 in gastroenterologists/ 中华消化杂志","authors":"Hui Liu, Bin Wang, Kaijun Liu, Liangzhi Wen, Xing-wei Wang, Qin Li, Huiru Zhang, Dongfeng Chen, Yanling Wei, Hongli Cui, Yanmei Zhang","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.03.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.03.005","url":null,"abstract":"Objective@#To investigate awareness of digestive system injury caused by corona virus disease 2019 (COVID-19) in gastroenterologists.@*Methods@#From February 21 to 23 in 2020, the electronic questionnaire was sent out to explore the condition of the basic knowledge of COVID-19 and knowledge of digestive system injury caused by COVID-19 grasped by gastroenterologists. Chi-square test was used for statistical analysis.@*Results@#A total of 2 216 gastroenterologists from 31 provinces, autonomous regions and municipalities nationwide completed the survey. 99.7% (2 209/2 216) of gastroenterologists stated that they had read the COVID-19 diagnosis and treatment guidelines. The percentage of physicians who well knew the diagnostic criteria of suspected and confirmed cases of COVID-19 was 34.9% (774/2 216) and 39.4% (874/2 216), respectively. The percentage of physician who gave the right answer of COVID-19 detectable methods and lung imaging was 68.4% (1 516/2 216) and 71.6% (1 586/2 216), respectively. The percentage of correct answer of digestive system injury caused by COVID-19 in residents, attending physicians, associate chief physicians and chief physicians was 30.9% (134/433), 33.9% (234/691), 32.4% (213/657) and 34.9% (152/435), respectively, however there were no statistically significant differences among physicians of different level (χ2=6.60, P> 0.05). 95.6% (2 119/2 216) of gastroenterologists believed that probiotics could effectively improve bowel function, and 94.0% (2 082/2 216) of gastroenterologists considered that enteral nutrition support could improve patients’ prognosis.@*Conclusions@#The knowledge and dynamic progress of the digestive system injury caused of COVID-19 are still insufficiently grasped by gastroenterologists in China. So it is necessary to carry out systematic and pertinent training for them.","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"44 1","pages":"162-166"},"PeriodicalIF":0.0,"publicationDate":"2020-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74956117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Attention to the damage of 2019 novel coronavirus to digestive system and the possibility of fecal-oral transmission 关注新型冠状病毒对消化系统的损害及粪口传播的可能性
Pub Date : 2020-02-29 DOI: 10.3760/CMA.J.CN311367-20200225-00090
X. Hou
Since the end of December 2019, new coronavirus pneumonia (COVID-19) gradually rapid spread to all over the country, which with strong infectious and had become a major public health event concerned by the whole country. Although scientists devote to the research of COVID-19, however so far some public health related key factors such as the mode of virus transmission and infection route, are just known little. Current researches suggest that in addition to respiratory transmission, 2019 novel coronaviruses (2019-nCoV) may also have fecal-oral transmission. In clinical practice, it was found that part of patients initially present with gastrointestinal symptoms, and not a few patients are with digestive system injury. These findings put forward new requirements of COVID-19 prevention and therapeutic strategy. Key words: COVID-19; SARS-CoV-2; Digestive system damage; fecal-oral transmission
2019年12月底以来,新型冠状病毒肺炎(COVID-19)逐步快速向全国蔓延,具有很强的传染性,已成为全国关注的重大公共卫生事件。尽管科学家们致力于新冠肺炎的研究,但迄今为止,一些与公共卫生相关的关键因素,如病毒传播方式和感染途径,知之甚少。目前的研究表明,2019新型冠状病毒(2019- ncov)除了呼吸道传播外,还可能存在粪口传播。在临床实践中发现,部分患者最初表现为胃肠道症状,也有不少患者存在消化系统损伤。这些发现对COVID-19的防治策略提出了新的要求。关键词:COVID-19;SARS-CoV-2;消化系统损伤;粪口传播
{"title":"Attention to the damage of 2019 novel coronavirus to digestive system and the possibility of fecal-oral transmission","authors":"X. Hou","doi":"10.3760/CMA.J.CN311367-20200225-00090","DOIUrl":"https://doi.org/10.3760/CMA.J.CN311367-20200225-00090","url":null,"abstract":"Since the end of December 2019, new coronavirus pneumonia (COVID-19) gradually rapid spread to all over the country, which with strong infectious and had become a major public health event concerned by the whole country. Although scientists devote to the research of COVID-19, however so far some public health related key factors such as the mode of virus transmission and infection route, are just known little. Current researches suggest that in addition to respiratory transmission, 2019 novel coronaviruses (2019-nCoV) may also have fecal-oral transmission. In clinical practice, it was found that part of patients initially present with gastrointestinal symptoms, and not a few patients are with digestive system injury. These findings put forward new requirements of COVID-19 prevention and therapeutic strategy. \u0000 \u0000 \u0000Key words: \u0000COVID-19; SARS-CoV-2; Digestive system damage; fecal-oral transmission","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72716073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Manifestations of Digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study/ 中华消化杂志 武汉新型冠状病毒肺炎住院患者消化系统表现:一项单中心描述性研究
Pub Date : 2020-02-23 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.0005
Dan Fang, Jingdong Ma, Jia-Lun Guan, Mu-ru Wang, Yang Song, D. Tian, Pei-Yuan Li
Objective@#To study the manifestations of digestive system of hospitalized patients with novel coronavirus pneumonia (NCP) in Wuhan, China, and to provide reference for disease control and treatment.@*Methods@#The data of hospitalized patients with NCP in the Sino-French Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology was retrospectively analyzed, which included general information, nucleic acid test, severity degree of disease, incubation period, initial symptoms and manifestations of digestive system. The general information, positive rate of nucleic acid detection, and manifestations of digestive system were compared between critical patients who required non-invasive or invasive assisted ventilation (critical group) and non-critical patients without assisted ventilation (non-critical group). Continuous corrected chi-square test and independent sample median test were performed for statistical analysis.@*Results@#Among the 305 patients there were 146 males (47.9%) and 159 females (52.1%), median age 57 years old. Nucleic acid assay of nasopharynx swab or pharynx swab of 84.1% (228/271) patients were positive. Forty-six patients (15.1%) were in critical group and 259 patients (84.9%) were in non-critical group. The incubation period was one to fifteen days, and the median period was six days. The initial symptoms mainly were fever (81.1%, 163/201), cough (39.3%, 79/201), fatigue (54.7%, 110/201), and loss of appetite (50.2%, 101/201). In one to ten days after the disease onset, 79.1% (159/201) of patients developed gastrointestinal symptoms including nausea (29.4%, 59/201), vomiting (15.9%, 32/201), or abdominal pain (6.0%, 12/201). 49.5% (146/295) of patients had diarrhea, median time was 3.3 days, (3.3±1.6) times per day, and a duration of (4.1±2.5) days. Excluding possible drug-related diarrhea, the incidence of diarrhea still was 22.2%. Only 6.9% (4/58) of patients were found leukocytes or fecal occult blood positive in regular stool test. ALT, AST, or bilirubin increased in 39.1% (119/304) of patients at admission. Patients with ALT or AST ≥ 80 U/L only accounted for 7.9% (24/304) and 6.3% (19/304), respectively. About 2.0% (6/304) of patients also had increased bilirubin level, average level was (37.4 ± 21.1) μmol/L. The median age of critical group was older than that of non-critical group (65.5 years vs. 56 years), at admission the rates of abnormal liver function test abnormal and slightly increased AST (40~80 U/L) of critical group were both higher than those of non-critical group (67.4% (31/46) vs. 34.1% (88/258) and 47.8% (22/46) vs. 21.7% (56/228)), and the differences were statistically significant (x2=5.885, 18.154 and 15.723;all P 0.05).@*Conclusions@#The manifestation of digestive system of hospitalized NCP patients in Wuhan is significant, the ratio of patients with diarrhea and abnormal aminotransferase level is high. And at admission the rate of patients with abnormal liver fu
目的了解武汉市新型冠状病毒肺炎(NCP)住院患者的消化系统表现,为疾病控制和治疗提供参考。方法回顾性分析华中科技大学同济医学院同济医院中法分院收治的新型冠状病毒肺炎住院患者的一般资料、核酸检测、病情严重程度、潜伏期、首发症状及消化系统表现。比较需要无创或有创辅助通气的危重患者(危重组)与不需要辅助通气的非危重患者(非危重组)的一般信息、核酸检测阳性率及消化系统表现。采用连续校正卡方检验和独立样本中位数检验进行统计分析。结果305例患者中,男性146例(47.9%),女性159例(52.1%),中位年龄57岁。鼻咽拭子或咽拭子核酸检测阳性的占84.1%(228/271)。危重组46例(15.1%),非危重组259例(84.9%)。潜伏期为1至15天,中位期为6天。首发症状主要为发热(81.1%,163/201)、咳嗽(39.3%,79/201)、乏力(54.7%,110/201)、食欲减退(50.2%,101/201)。发病后1 ~ 10天,79.1%(159/201)的患者出现恶心(29.4%,59/201)、呕吐(15.9%,32/201)、腹痛(6.0%,12/201)等胃肠道症状。49.5%(146/295)的患者出现腹泻,中位时间为3.3 d,每天(3.3±1.6)次,持续时间为(4.1±2.5)d。排除可能的药物相关性腹泻,腹泻发生率仍为22.2%。仅6.9%(4/58)的患者在常规大便检查中发现白细胞或粪便隐血阳性。入院时患者ALT、AST或胆红素升高39.1%(119/304)。ALT或AST≥80u /L的患者分别占7.9%(24/304)和6.3%(19/304)。约2.0%(6/304)患者胆红素水平升高,平均为(37.4±21.1)μmol/L。危重组患者年龄中位数大于非危重组(65.5岁比56岁),入院时肝功能检查异常及AST (40~80 U/L)略增高率均高于非危重组(67.4%(31/46)比34.1%(88/258)、47.8%(22/46)比21.7%(56/228)),差异均有统计学意义(x2=5.885、18.154、15.723,均P 0.05)。结论武汉市住院新型冠状病毒感染患者消化系统表现明显,腹泻和转氨酶水平异常的患者比例较高。危重组患者入院时肝功能异常发生率高于非危重组,为新型冠状病毒感染的防治提供参考。
{"title":"Manifestations of Digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study/ 中华消化杂志","authors":"Dan Fang, Jingdong Ma, Jia-Lun Guan, Mu-ru Wang, Yang Song, D. Tian, Pei-Yuan Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.0005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.0005","url":null,"abstract":"Objective@#To study the manifestations of digestive system of hospitalized patients with novel coronavirus pneumonia (NCP) in Wuhan, China, and to provide reference for disease control and treatment.@*Methods@#The data of hospitalized patients with NCP in the Sino-French Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology was retrospectively analyzed, which included general information, nucleic acid test, severity degree of disease, incubation period, initial symptoms and manifestations of digestive system. The general information, positive rate of nucleic acid detection, and manifestations of digestive system were compared between critical patients who required non-invasive or invasive assisted ventilation (critical group) and non-critical patients without assisted ventilation (non-critical group). Continuous corrected chi-square test and independent sample median test were performed for statistical analysis.@*Results@#Among the 305 patients there were 146 males (47.9%) and 159 females (52.1%), median age 57 years old. Nucleic acid assay of nasopharynx swab or pharynx swab of 84.1% (228/271) patients were positive. Forty-six patients (15.1%) were in critical group and 259 patients (84.9%) were in non-critical group. The incubation period was one to fifteen days, and the median period was six days. The initial symptoms mainly were fever (81.1%, 163/201), cough (39.3%, 79/201), fatigue (54.7%, 110/201), and loss of appetite (50.2%, 101/201). In one to ten days after the disease onset, 79.1% (159/201) of patients developed gastrointestinal symptoms including nausea (29.4%, 59/201), vomiting (15.9%, 32/201), or abdominal pain (6.0%, 12/201). 49.5% (146/295) of patients had diarrhea, median time was 3.3 days, (3.3±1.6) times per day, and a duration of (4.1±2.5) days. Excluding possible drug-related diarrhea, the incidence of diarrhea still was 22.2%. Only 6.9% (4/58) of patients were found leukocytes or fecal occult blood positive in regular stool test. ALT, AST, or bilirubin increased in 39.1% (119/304) of patients at admission. Patients with ALT or AST ≥ 80 U/L only accounted for 7.9% (24/304) and 6.3% (19/304), respectively. About 2.0% (6/304) of patients also had increased bilirubin level, average level was (37.4 ± 21.1) μmol/L. The median age of critical group was older than that of non-critical group (65.5 years vs. 56 years), at admission the rates of abnormal liver function test abnormal and slightly increased AST (40~80 U/L) of critical group were both higher than those of non-critical group (67.4% (31/46) vs. 34.1% (88/258) and 47.8% (22/46) vs. 21.7% (56/228)), and the differences were statistically significant (x2=5.885, 18.154 and 15.723;all P 0.05).@*Conclusions@#The manifestation of digestive system of hospitalized NCP patients in Wuhan is significant, the ratio of patients with diarrhea and abnormal aminotransferase level is high. And at admission the rate of patients with abnormal liver fu","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89240816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 99
Advances in the digestive system of coronavirus infected patients 冠状病毒感染者消化系统研究进展
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.003
Liping Chen, Weixia Li, Cheng Tian, Jilin Cheng
目前可感染人类的冠状病毒(HCoV)共有7种,其中严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和正在流行的2019新型冠状病毒(2019-nCoV)的危害性大、传染性强,这3种冠状病毒感染的患者多存在消化系统表现,故除呼吸系统外,消化系统可能是冠状病毒又一潜在的感染靶标。本文就SARS-CoV、MERS-CoV和2019-nCoV感染引发的消化系统症状及其相关研究进展加以综述,以加深临床医师对冠状病毒感染所致消化系统损害的认识,从而做到快速有效的诊疗。
目前可感染人类的冠状病毒(HCoV)共有7种,其中严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和正在流行的2019新型冠状病毒(2019-nCoV)的危害性大、传染性强,这3种冠状病毒感染的患者多存在消化系统表现,故除呼吸系统外,消化系统可能是冠状病毒又一潜在的感染靶标。本文就SARS-CoV、MERS-CoV和2019-nCoV感染引发的消化系统症状及其相关研究进展加以综述,以加深临床医师对冠状病毒感染所致消化系统损害的认识,从而做到快速有效的诊疗。
{"title":"Advances in the digestive system of coronavirus infected patients","authors":"Liping Chen, Weixia Li, Cheng Tian, Jilin Cheng","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.003","url":null,"abstract":"目前可感染人类的冠状病毒(HCoV)共有7种,其中严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和正在流行的2019新型冠状病毒(2019-nCoV)的危害性大、传染性强,这3种冠状病毒感染的患者多存在消化系统表现,故除呼吸系统外,消化系统可能是冠状病毒又一潜在的感染靶标。本文就SARS-CoV、MERS-CoV和2019-nCoV感染引发的消化系统症状及其相关研究进展加以综述,以加深临床医师对冠状病毒感染所致消化系统损害的认识,从而做到快速有效的诊疗。","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"76 1","pages":"80-82"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86071140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical characteristics and change trend of patients with Crohn′s disease at different onset times of perianal lesions 克罗恩病患者不同发病时间肛周病变的临床特点及变化趋势
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.007
Haichao Wang, C. Ye, Yaling Wu, Pengyu Yang, Zhanju Liu, Xiaolei Wang
Objective To investigate the clinical characteristics and change trend of patients with perianal lesions before or after Crohn′s disease (CD) diagnosed. Methods From January 2008 to September 2018, at The Tenth People′s Hospital Affiliated to Tongji University, the clinical data of 747 hospitalized CD patients were retrospectively collected, 293 patients were PCD patients. The clinical characteristics of PCD patients before or after CD diagnosed were analyzed and the change trend was followed. T test, Mann-Whitney U test, and Chi-square test were performed for statistical analysis. Multivariate logistic regression analysis was used to analyze factors associated with perianal lesions onset time. Spearman correlation analysis was used to analyze the change trend of clinical characteristics. Results Before CD diagnosis, 86.3% (253/293) PCD patients had perianal lesions. The median follow-up time (range) was 72 months (36 to 108 months). Compared with the patients presented with perianal lesions after CD diagnosis, the onset age of patients with perianal lesions before CD diagnosis was younger ((36.0±12.6) years vs. (24.2±10.2) years), and the rates of male (62.5%, 25/40 vs. 77.9%, 197/253), non-structuring and non-penetrating type (32.5%, 13/40 vs. 56.9%, 144/253) and perianal surgery (55.0%, 22/40 vs.76.7%, 194/253) were high, but low rate of abdominal surgery (37.5%, 15/40 vs. 13.0%, 33/253), and the differences were statistically significant (t=2.630, χ2=4.442, 8.379, 8.379 and 15.081; all P<0.05). The results of logistic multivariate analysis showed that before CD diagnosis, non-structuring and non-penetrating type was more common than structuring type (odds ratio (OR)=0.447, 95% confidence interval (CI) 0.207 to 0.962, P=0.039) and penetrating type (OR=0.264, 95%CI 0.089 to 0.780, P=0.016). The short disease duration of CD (OR=0.981, 95%CI 0.968 to 0.995, P=0.008), structuring type (OR=2.239, 95%CI 1.040 to 4.822, P=0.039) and penetrating type (OR=3.788, 95%CI 1.281 to 11.198, P=0.016) were the risk factors of perianal lesions after CD diagnosed. The number of PCD patients (r=0.964, P<0.01) and the proportion of biological agents (r=0.879, P<0.01) increased with years, while PCD duration (r=-0.828, P<0.01) and the rate of abdominal surgery significantly decreased with years (r=-0.882, P<0.01). The proportion of biological agents was negatively correlated with the rate of abdominal surgery (r=-0.770, P=0.006). Conclusions The perianal lesions should be closely monitored in adult CD patients with short disease duration, structuring type and penetrating type for early diagnosis and treatment. Biological agents can improve the clinical outcomes of PCD. Key words: Crohn disease; Perianal disease; Characteristics; Onset time; Trend
目的探讨克罗恩病(CD)确诊前后肛周病变的临床特点及变化趋势。方法回顾性收集2008年1月~ 2018年9月同济大学附属第十人民医院住院CD患者747例的临床资料,其中PCD患者293例。分析PCD患者诊断前后的临床特征,并跟踪其变化趋势。采用T检验、Mann-Whitney U检验和卡方检验进行统计学分析。多因素logistic回归分析与肛周病变发病时间的相关因素。采用Spearman相关分析分析临床特征的变化趋势。结果确诊前,86.3% (253/293)PCD患者存在肛周病变。中位随访时间(范围)为72个月(36 ~ 108个月)。与CD诊断后出现肛周病变的患者相比,CD诊断前出现肛周病变的患者发病年龄更年轻((36.0±12.6)岁vs(24.2±10.2)岁),且男性(25/40 vs 77.9%, 197/253)、非结构性非穿透型(32.5%,13/40 vs. 56.9%, 144/253)和肛周手术(55.0%,22/40 vs.76.7%, 1994 /253)发生率较高,腹部手术发生率较低(37.5%,15/40 vs. 13.0%, 33/253)。差异有统计学意义(t=2.630, χ2=4.442、8.379、8.379、15.081;所有P < 0.05)。logistic多因素分析结果显示,在CD诊断前,非结构化和非穿透型患者多于结构化型患者(优势比(OR)=0.447, 95%可信区间(CI) 0.207 ~ 0.962, P=0.039)和穿透型患者(OR=0.264, 95%CI 0.089 ~ 0.780, P=0.016)。CD病程短(OR=0.981, 95%CI 0.968 ~ 0.995, P=0.008)、结构型(OR=2.239, 95%CI 1.040 ~ 4.822, P=0.039)、穿透型(OR=3.788, 95%CI 1.281 ~ 11.198, P=0.016)是CD诊断后肛周病变的危险因素。PCD患者数(r=0.964, P<0.01)和生物制剂比例(r=0.879, P<0.01)随年龄增加而增加,PCD病程(r=-0.828, P<0.01)和腹部手术率随年龄增加而显著降低(r=-0.882, P<0.01)。生物制剂比例与腹部手术率呈负相关(r=-0.770, P=0.006)。结论病程短、结构型和穿透型的成年CD患者应密切监测肛周病变,以便早期诊断和治疗。生物制剂可改善PCD的临床预后。关键词:克罗恩病;肛周疾病;特征;发病时间;趋势
{"title":"Clinical characteristics and change trend of patients with Crohn′s disease at different onset times of perianal lesions","authors":"Haichao Wang, C. Ye, Yaling Wu, Pengyu Yang, Zhanju Liu, Xiaolei Wang","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.007","url":null,"abstract":"Objective \u0000To investigate the clinical characteristics and change trend of patients with perianal lesions before or after Crohn′s disease (CD) diagnosed. \u0000 \u0000 \u0000Methods \u0000From January 2008 to September 2018, at The Tenth People′s Hospital Affiliated to Tongji University, the clinical data of 747 hospitalized CD patients were retrospectively collected, 293 patients were PCD patients. The clinical characteristics of PCD patients before or after CD diagnosed were analyzed and the change trend was followed. T test, Mann-Whitney U test, and Chi-square test were performed for statistical analysis. Multivariate logistic regression analysis was used to analyze factors associated with perianal lesions onset time. Spearman correlation analysis was used to analyze the change trend of clinical characteristics. \u0000 \u0000 \u0000Results \u0000Before CD diagnosis, 86.3% (253/293) PCD patients had perianal lesions. The median follow-up time (range) was 72 months (36 to 108 months). Compared with the patients presented with perianal lesions after CD diagnosis, the onset age of patients with perianal lesions before CD diagnosis was younger ((36.0±12.6) years vs. (24.2±10.2) years), and the rates of male (62.5%, 25/40 vs. 77.9%, 197/253), non-structuring and non-penetrating type (32.5%, 13/40 vs. 56.9%, 144/253) and perianal surgery (55.0%, 22/40 vs.76.7%, 194/253) were high, but low rate of abdominal surgery (37.5%, 15/40 vs. 13.0%, 33/253), and the differences were statistically significant (t=2.630, χ2=4.442, 8.379, 8.379 and 15.081; all P<0.05). The results of logistic multivariate analysis showed that before CD diagnosis, non-structuring and non-penetrating type was more common than structuring type (odds ratio (OR)=0.447, 95% confidence interval (CI) 0.207 to 0.962, P=0.039) and penetrating type (OR=0.264, 95%CI 0.089 to 0.780, P=0.016). The short disease duration of CD (OR=0.981, 95%CI 0.968 to 0.995, P=0.008), structuring type (OR=2.239, 95%CI 1.040 to 4.822, P=0.039) and penetrating type (OR=3.788, 95%CI 1.281 to 11.198, P=0.016) were the risk factors of perianal lesions after CD diagnosed. The number of PCD patients (r=0.964, P<0.01) and the proportion of biological agents (r=0.879, P<0.01) increased with years, while PCD duration (r=-0.828, P<0.01) and the rate of abdominal surgery significantly decreased with years (r=-0.882, P<0.01). The proportion of biological agents was negatively correlated with the rate of abdominal surgery (r=-0.770, P=0.006). \u0000 \u0000 \u0000Conclusions \u0000The perianal lesions should be closely monitored in adult CD patients with short disease duration, structuring type and penetrating type for early diagnosis and treatment. Biological agents can improve the clinical outcomes of PCD. \u0000 \u0000 \u0000Key words: \u0000Crohn disease; Perianal disease; Characteristics; Onset time; Trend","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"298 1","pages":"99-104"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80626833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of patients with autoimmune liver disease complicated with gallbladder stone 自身免疫性肝病合并胆囊结石患者的临床特点
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.008
Man Liu, Zhong-qing Zheng, Simin Zhou, Hongxia Zhang, H. Chu, Xiaoyi Wang, Jie Zhang, Lu Zhou, Bangmao Wang
Objective To explore the clinical characteristics of liver function of patients with autoimmune liver disease (AILD) complicated with gallbladder stone (GS), so as to guide clinical practice. Methods From November 2009 to October 2018, at General Hospital of Tianjin Medical University, the clinical data of 386 patients with AILD were retrospectively analyzed. According to the relevant diagnostic criteria, 208 cases of autoimmune hepatitis (AIH), 129 cases of primary biliary cholangitis (PBC) and 49 cases of PBC-AIH overlap syndrome were screened out. The incidence, clinical characteristics and the changes of laboratory indicators including albumin, alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) of AILD patients complicated with GS were analyzed. Chi-square test, t test and rank sum test were performed for statistical analysis. Results There was no significant difference in the incidence between AILD, AIH, PBC and PBC-AIH overlap syndrome patients complicated with GS (32.9%, 127/386; 28.8%, 60/208; 36.4%, 47/129 and 40.8%, 20/49; respectively; P>0.05). Gallstones of AILD patients complicated with GS mostly were multiple and small stones with maximum diameter <1 cm (45.7%, 58/127 and 57.7%, 60/104, respectively). The age of initial diagnosis, the proportion of liver cirrhosis at inital diagnosis and the levels of ALP and GGT were higher in AILD patients complicated with GS than those of AILD patients without GS ((60.5±11.5) years vs. (57.6±11.5) years; 53.5%, 68/127 vs. 42.1%, 109/259; 154.00 U/L (89.00 U/L, 257.00 U/L) vs. 125.00 U/L (86.00 U/L, 212.00 U/L); 169.00 U/L (79.00 U/L, 343.00 U/L) vs. 128.60 U/L (48.00 U/L, 284.00 U/L); respectively); however the albumin level was lower than that of AILD patients without GS ((36.46±7.30) g/L vs. (38.34±7.58) g/L), and the differences were statistically significant (t=-2.361, χ2=4.506, Z=-2.192, -2.443, t=2.322; all P<0.05). The incidence of GS in AILD patients≥60 years old was higher than that AILD patients<60 years old (37.6%, 73/194 vs. 28.1%, 54/192), and the difference was statistically significant (χ2=3.948, P=0.047). The incidence of GS in AILD patients and AIH patients complicated with liver cirrhosis was higher than that in patients without liver cirrhosis (38.4%, 68/177 vs. 28.2%, 59/209; 35.7%, 35/98 vs. 22.7%, 25/110; respectively), and the differences were statistically significant (χ2=4.506 and 4.259, P=0.034 and 0.039). Conclusions AILD patients complicated with GS are common, most are multiple and small stones. When complicated with GS, the initial diagnosis may be delayed and the rate of liver cirrhosis at initial diagnosis may increase. The incidence of GS is high in AILD patients with older age and liver cirrhosis. Key words: Liver cirrhosis; Autoimmune liver disease; Gallbladder stone; Liver function; Age
目的探讨自身免疫性肝病(AILD)合并胆囊结石(GS)患者肝功能的临床特点,以指导临床实践。方法回顾性分析2009年11月至2018年10月天津医科大学总医院386例AILD患者的临床资料。根据相关诊断标准,筛选出自身免疫性肝炎(AIH) 208例,原发性胆道胆管炎(PBC) 129例,PBC-AIH重叠综合征49例。分析AILD合并GS患者白蛋白、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)等实验室指标的发生率、临床特点及变化。采用卡方检验、t检验和秩和检验进行统计学分析。结果AILD、AIH、PBC及PBC-AIH重叠综合征合并GS患者的发病率差异无统计学意义(32.9%,127/386;28.8%, 60/208;36.4%(47/129)和40.8% (20/49);分别;P > 0.05)。AILD合并GS患者的胆结石多为多发、小结石,最大直径<1 cm,分别为45.7%(58/127)和57.7%(60/104)。合并GS的AILD患者的初诊年龄、初诊肝硬化比例及ALP、GGT水平均高于不合并GS的AILD患者(60.5±11.5)岁∶(57.6±11.5)岁;53.5%, 68/127 vs. 42.1%, 109/259;154.00 U/L (89.00 U/L, 257.00 U/L) vs. 125.00 U/L (86.00 U/L, 212.00 U/L);169.00 U/L (79.00 U/L, 343.00 U/L) vs. 128.60 U/L (48.00 U/L, 284.00 U/L);分别);但白蛋白水平低于不伴GS的AILD患者((36.46±7.30)g/L vs(38.34±7.58)g/L),差异有统计学意义(t=-2.361, χ2=4.506, Z=-2.192, -2.443, t=2.322;所有P < 0.05)。≥60岁AILD患者GS发生率高于<60岁AILD患者(37.6%,73/194比28.1%,54/192),差异有统计学意义(χ2=3.948, P=0.047)。AILD患者和AIH合并肝硬化患者GS发生率高于无肝硬化患者(38.4%,68/177比28.2%,59/209;35.7% (35/98) vs 22.7% (25/110);),差异有统计学意义(χ2=4.506、4.259,P=0.034、0.039)。结论AILD合并GS患者较为常见,多为多发小结石。当合并GS时,初始诊断可能会延迟,并且初始诊断时肝硬化的发生率可能会增加。高龄合并肝硬化的AILD患者GS发生率高。关键词:肝硬化;自身免疫性肝病;胆囊结石;肝功能;年龄
{"title":"Clinical characteristics of patients with autoimmune liver disease complicated with gallbladder stone","authors":"Man Liu, Zhong-qing Zheng, Simin Zhou, Hongxia Zhang, H. Chu, Xiaoyi Wang, Jie Zhang, Lu Zhou, Bangmao Wang","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.008","url":null,"abstract":"Objective \u0000To explore the clinical characteristics of liver function of patients with autoimmune liver disease (AILD) complicated with gallbladder stone (GS), so as to guide clinical practice. \u0000 \u0000 \u0000Methods \u0000From November 2009 to October 2018, at General Hospital of Tianjin Medical University, the clinical data of 386 patients with AILD were retrospectively analyzed. According to the relevant diagnostic criteria, 208 cases of autoimmune hepatitis (AIH), 129 cases of primary biliary cholangitis (PBC) and 49 cases of PBC-AIH overlap syndrome were screened out. The incidence, clinical characteristics and the changes of laboratory indicators including albumin, alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) of AILD patients complicated with GS were analyzed. Chi-square test, t test and rank sum test were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000There was no significant difference in the incidence between AILD, AIH, PBC and PBC-AIH overlap syndrome patients complicated with GS (32.9%, 127/386; 28.8%, 60/208; 36.4%, 47/129 and 40.8%, 20/49; respectively; P>0.05). Gallstones of AILD patients complicated with GS mostly were multiple and small stones with maximum diameter <1 cm (45.7%, 58/127 and 57.7%, 60/104, respectively). The age of initial diagnosis, the proportion of liver cirrhosis at inital diagnosis and the levels of ALP and GGT were higher in AILD patients complicated with GS than those of AILD patients without GS ((60.5±11.5) years vs. (57.6±11.5) years; 53.5%, 68/127 vs. 42.1%, 109/259; 154.00 U/L (89.00 U/L, 257.00 U/L) vs. 125.00 U/L (86.00 U/L, 212.00 U/L); 169.00 U/L (79.00 U/L, 343.00 U/L) vs. 128.60 U/L (48.00 U/L, 284.00 U/L); respectively); however the albumin level was lower than that of AILD patients without GS ((36.46±7.30) g/L vs. (38.34±7.58) g/L), and the differences were statistically significant (t=-2.361, χ2=4.506, Z=-2.192, -2.443, t=2.322; all P<0.05). The incidence of GS in AILD patients≥60 years old was higher than that AILD patients<60 years old (37.6%, 73/194 vs. 28.1%, 54/192), and the difference was statistically significant (χ2=3.948, P=0.047). The incidence of GS in AILD patients and AIH patients complicated with liver cirrhosis was higher than that in patients without liver cirrhosis (38.4%, 68/177 vs. 28.2%, 59/209; 35.7%, 35/98 vs. 22.7%, 25/110; respectively), and the differences were statistically significant (χ2=4.506 and 4.259, P=0.034 and 0.039). \u0000 \u0000 \u0000Conclusions \u0000AILD patients complicated with GS are common, most are multiple and small stones. When complicated with GS, the initial diagnosis may be delayed and the rate of liver cirrhosis at initial diagnosis may increase. The incidence of GS is high in AILD patients with older age and liver cirrhosis. \u0000 \u0000 \u0000Key words: \u0000Liver cirrhosis; Autoimmune liver disease; Gallbladder stone; Liver function; Age","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"13 5 1","pages":"105-109"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78398774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical value of sequential organ failure assessment score in evaluating organ function in acute pancreatitis 顺序脏器功能衰竭评分评价急性胰腺炎脏器功能的临床价值
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.0254-1432.2020.02.009
Xi Zheng, Lei Li, Yin Zhu, N. Lyu, W. He
Objective To compare the clinical value of sequential organ failure assessment (SOFA) score and revised Marshall score in evaluating organ function in acute pancreatitis (AP). Methods From January 2013 to December 2017, at the Department of Gastroenterology of The First Affiliated Hospital of Nanchang University, the clinical data of 3 957 hospitalized AP patients were collected through the AP electronic database. AP was diagnosed and the severity of the disease was classified according to the revised Atlanta classification criteria. Organ function was evaluated by modified Marshall score and SOFA score. The correlation between SOFA score and mortality, pancreatic necrosis were analyzed. Chi-square test and Spearman correlation analysis were performed for statistical analysis. Results The incidences of circulatory failure and renal failure determined by the SOFA score were higher than those of the modified Marshall score (4.80%, 190/3 957 vs. 3.03%, 120/3 957; 10.11%, 400/3 957 vs. 6.44%, 255/3 957), and the differences were statistically significant (χ2=1 599.54 and 2 237.19, both P<0.01). Two score systems were consistent in determining the incidence of respiratory failure, which were 32.22% (1 275/3 957). The incidences of persistent circulatory failure (≥48 h) and persistent renal failure (≥48 h) determined by the SOFA score were higher than those of the modified Marshall score (1.64%, 65/3 957 vs. 0.76%, 30/3 957; 4.78%, 189/3 957 vs. 3.69%, 146/3 957), and the differences were statistically significant (χ2=1 458.37 and 2 398.01, both P<0.01). The incidence of persistent respiratory failure (≥48 h) was same determined by two score systems, which were 10.24% (405/3 957). The proportion of patients with severe AP determined by SOFA score was higher than that of the modified Marshall score (25.30%, 1 001/3 957 vs. 18.83%, 745/3 957), and the difference was statistically significant (χ2=718.216, P<0.01). The results of Spearman correlation analysis showed that SOFA total score was positively correlated with the overall mortality and the incidence of pancreatic necrosis (correlation coefficients r were 0.540 and 0.211, respectively), and the differences were statistically significant (both P<0.01). Conclusion SOFA score can comprehensively evaluate organ function in AP and is an important approach in determining prognosis. Key words: Sequential organ failure assessment score; Acute pancreatitis; Revised Marshall score; Organ function
目的比较顺序脏器功能衰竭评分(SOFA)与修正Marshall评分在急性胰腺炎(AP)脏器功能评价中的临床价值。方法通过AP电子数据库收集2013年1月至2017年12月南昌大学第一附属医院消化内科住院的3 957例AP患者的临床资料。诊断出AP,并根据修订的亚特兰大分类标准对疾病的严重程度进行分类。采用改良Marshall评分和SOFA评分评价脏器功能。分析SOFA评分与死亡率、胰腺坏死的相关性。采用卡方检验和Spearman相关分析进行统计学分析。结果SOFA评分判定循环衰竭和肾功能衰竭的发生率高于改良Marshall评分(4.80%,190/3 957比3.03%,120/3 957;10.11%(400/3 957)对6.44%(255/3 957),差异有统计学意义(χ2=1 599.54、2 237.19,P均<0.01)。两种评分系统在判断呼吸衰竭发生率方面一致,均为32.22%(1 275/3 957)。SOFA评分判定持续性循环衰竭(≥48 h)和持续性肾衰(≥48 h)的发生率高于改良Marshall评分(1.64%,65/3 957 vs 0.76%, 30/3 957;4.78%(189/3 957)对3.69%(146/3 957),差异均有统计学意义(χ2=1 458.37、2 398.01,P均<0.01)。两种评分系统对持续呼吸衰竭(≥48 h)的发生率相同,均为10.24%(405/3 957)。SOFA评分判定严重AP的患者比例高于改良Marshall评分(25.30%,1 001/3 957比18.83%,745/3 957),差异有统计学意义(χ2=718.216, P<0.01)。Spearman相关分析结果显示,SOFA总分与总死亡率、胰腺坏死发生率呈正相关(相关系数r分别为0.540、0.211),差异均有统计学意义(P<0.01)。结论SOFA评分可综合评价AP脏器功能,是判断预后的重要指标。关键词:序贯性器官衰竭评分;急性胰腺炎;修订马歇尔分数;器官功能
{"title":"Clinical value of sequential organ failure assessment score in evaluating organ function in acute pancreatitis","authors":"Xi Zheng, Lei Li, Yin Zhu, N. Lyu, W. He","doi":"10.3760/CMA.J.ISSN.0254-1432.2020.02.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2020.02.009","url":null,"abstract":"Objective \u0000To compare the clinical value of sequential organ failure assessment (SOFA) score and revised Marshall score in evaluating organ function in acute pancreatitis (AP). \u0000 \u0000 \u0000Methods \u0000From January 2013 to December 2017, at the Department of Gastroenterology of The First Affiliated Hospital of Nanchang University, the clinical data of 3 957 hospitalized AP patients were collected through the AP electronic database. AP was diagnosed and the severity of the disease was classified according to the revised Atlanta classification criteria. Organ function was evaluated by modified Marshall score and SOFA score. The correlation between SOFA score and mortality, pancreatic necrosis were analyzed. Chi-square test and Spearman correlation analysis were performed for statistical analysis. \u0000 \u0000 \u0000Results \u0000The incidences of circulatory failure and renal failure determined by the SOFA score were higher than those of the modified Marshall score (4.80%, 190/3 957 vs. 3.03%, 120/3 957; 10.11%, 400/3 957 vs. 6.44%, 255/3 957), and the differences were statistically significant (χ2=1 599.54 and 2 237.19, both P<0.01). Two score systems were consistent in determining the incidence of respiratory failure, which were 32.22% (1 275/3 957). The incidences of persistent circulatory failure (≥48 h) and persistent renal failure (≥48 h) determined by the SOFA score were higher than those of the modified Marshall score (1.64%, 65/3 957 vs. 0.76%, 30/3 957; 4.78%, 189/3 957 vs. 3.69%, 146/3 957), and the differences were statistically significant (χ2=1 458.37 and 2 398.01, both P<0.01). The incidence of persistent respiratory failure (≥48 h) was same determined by two score systems, which were 10.24% (405/3 957). The proportion of patients with severe AP determined by SOFA score was higher than that of the modified Marshall score (25.30%, 1 001/3 957 vs. 18.83%, 745/3 957), and the difference was statistically significant (χ2=718.216, P<0.01). The results of Spearman correlation analysis showed that SOFA total score was positively correlated with the overall mortality and the incidence of pancreatic necrosis (correlation coefficients r were 0.540 and 0.211, respectively), and the differences were statistically significant (both P<0.01). \u0000 \u0000 \u0000Conclusion \u0000SOFA score can comprehensively evaluate organ function in AP and is an important approach in determining prognosis. \u0000 \u0000 \u0000Key words: \u0000Sequential organ failure assessment score; Acute pancreatitis; Revised Marshall score; Organ function","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"26 1","pages":"110-114"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90360266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
中华消化杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1